Virtually every ‘device capability’ you mention is the function of patient-identified, HCP-specific, application integration, delivered over whatever network is deployed, delivered by whatever device is secure.

Again, enterprise-wide IT Architecture, Application integration , standards-based data stores, stable systems have been the HCIT challenge for decades. Another expensive device launch will again drive this lesson home for the HC industry, once again.

So to be clear, how does a new device (cool as it is) accelerate reimbursement? Deliver Decision-support? Report on outcome measures?

Everyone needs more effective communication, so you can expect Voalté on both platforms

Rob Campbell
Voalté

We think the answers are: “no,” “probably,” and “how strong.” They’ll still want the performance and pocket-sized convenience of the iPhone for their phone needs, but undoubtedly a significant group will add the iPad as either their individual in-clinic device (or perhaps as a shared resource tool for multiple users).

While here at Blausen Medical we’ve obviously got a dog in the fight with our Human Atlas iPhone app (www.Blausen.com/iphone), we can see the dramatic enhancement in viewing our animations on a screen twice as large as the iPhone. The advantages in delivering point of care patient education are enormous, and coupled with the ease for new users of downloading from the iTunes App Store, or transferring already purchased apps from their iPhones, make the new iPad a natural.

We’ll see where this goes, but aside from all the buzz about the iPad’s e-reader and gaming strengths, we believe it could drive additional momentum behind the already bubbling area of mobile communication in the healthcare vertical.

Bruce Blausen
Blausen Medical